Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_020975.6(RET):c.1438G>A(p.Glu480Lys) variant causes a missense change. The variant allele was found at a frequency of 0.000129 in 1,613,958 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E480D) has been classified as Uncertain significance.
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA Uncertain:2
Uncertain significance, criteria provided, single submitter
clinical testing
Counsyl
Dec 04, 2015
- -
Uncertain significance, criteria provided, single submitter
clinical testing
Mendelics
May 28, 2019
- -
Hereditary cancer-predisposing syndrome Benign:2
Likely benign, criteria provided, single submitter
curation
Sema4, Sema4
Feb 16, 2022
- -
Likely benign, criteria provided, single submitter
clinical testing
Ambry Genetics
Dec 05, 2018
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hirschsprung disease, susceptibility to, 1 Pathogenic:1
Likely pathogenic, flagged submission
research
Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS
Feb 22, 2019
- -
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB Uncertain:1
Uncertain significance, criteria provided, single submitter
clinical testing
Counsyl
Dec 04, 2015
- -
Multiple endocrine neoplasia, type 2 Benign:1
Likely benign, criteria provided, single submitter
clinical testing
Invitae
Jan 24, 2024
- -
not provided Benign:1
Likely benign, criteria provided, single submitter
clinical testing
GeneDx
Nov 20, 2020
In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31742715, 18280283, 24728327, 12628594, 22174939, 11436122, 26152202) -